Diginex's October Ballot: A $600 Million Share Issuance Meets a Widening Loss Base

Diginex seeks approval for 600M shares for Resulticks deal and $20M raise, but losses widen and stock falls 25% in a week.

The arithmetic facing Diginex shareholders ahead of the October 8 extraordinary general meeting is unforgiving. The Nasdaq-listed firm is asking investors to approve a 600 million-share issuance tied to its Resulticks Global Companies acquisition — priced at $1.75 per share — while simultaneously digesting a $20 million capital raise that adds another 20 million shares and matching five-year warrants to the register. The stock closed Monday at $1.21, down 8.3 percent on the day and roughly 25 percent lower over the past seven trading sessions.

The share price erosion has unfolded against a backdrop of heavy corporate activity. On August 13, Diginex unveiled the $20 million financing package, structured as 20 million common shares plus warrants exercisable at $1.00 apiece. The proceeds are scheduled to land between July 28, 2026, and March 31, 2027, complementing $70 million in private financing commitments the company says it has already secured. Those commitments came together after the long-stop date for the Resulticks deal was pushed from late July to August 12 — the same day trading in the stock was suspended on the Nasdaq at 9:15 a.m. ET, a halt that added to investor unease.

A Growth Story With a Costly Shadow

The audited results for the fiscal year ended March 31, 2026, released earlier, frame the dilemma. Revenue climbed 77 percent to $3.6 million from $2.0 million, propelled by the consolidation of acquisitions including Matter, Remedy, and Plan A. But the net loss ballooned to $31.2 million from $5.2 million the prior year, with an operating loss of $24.9 million and an adjusted EBITDA loss of $13.0 million. A $7.0 million goodwill impairment tied to the Matter acquisition was a notable drag — a signal that at least one purchased business has underperformed its original promise.

The loss trajectory matters because it intersects with the dilution math. The 600 million Resulticks shares alone dwarf the company's existing float, and the separate $20 million raise layers on additional equity and warrant exposure. With the net loss now roughly six times the prior-year figure, the per-share value calculus becomes increasingly strained.

Two Scenarios, One Ballot

The bull case rests on execution. If Diginex draws down the $70 million in private commitments and completes the $20 million raise on schedule, the Resulticks acquisition would be funded without immediate liquidity pressure. The 77 percent revenue growth suggests operational momentum, and a successful October vote followed by a deal closing by October 30 would create a substantially larger enterprise. Under that scenario, the current share weakness could look like pre-dilution overshooting.

The bear case is about the sheer weight of new paper. Between the Resulticks issuance and the separate financing, the share count expands dramatically while losses run at multiples of prior-year levels. The Nasdaq trading halt and the long-stop extension hint at friction in the acquisition process itself. If the October meeting rejects the issuance — or the closing slips past the October 30 target — Diginex would face its financing commitments without the growth platform they were meant to fund.

What the Metrics Say

The market's verdict is currently cautious but not panicked. The relative strength index sits at 40.1, suggesting neutral-to-weak momentum rather than oversold conditions. Annualized 30-day volatility of 120 percent reflects the scale of uncertainty. With a market capitalization of approximately €33.15 million, Diginex remains a small cap whose price swings are likely to persist through the vote and the subsequent closing window.

The record date for voting eligibility is August 14, and the agenda includes not only the Resulticks share purchase agreement but also an increase in authorized capital and amended articles of association. The next concrete test is clearly scheduled: the October 8 meeting, followed by the targeted closing at month's end. Between now and then, the market will be watching whether the promised financing actually arrives — and at what cost to existing shareholders.